Inaugural Meeting of Irish Neuroendocrine Neoplasm Group

The inaugural meeting of the Irish Neuroendocrine Neoplasm Group was held at Trinity College Dublin.  Irish and international experts in carcinoid/NETs gathered to discuss advances in the field, diagnostic and therapeutic practices currently available in Ireland, as well as areas where Ireland is falling behind, especially in specialized nuclear medicine diagnostic and therapy tools.  Commenting on the meeting, organiser and co-chair of the Scientific Committee, Dr Dermot O’Toole, Associate Professor of Clinical Medicine, TCD said: “This meeting afforded the opportunity for a diverse range of physicians and surgeons with an interest in this disease to come together for an educational day but the meeting also formed the backbone in paving the way for developing a recognised Irish Network to provide care for patients with this disease. There is a strong kernel of real experts in this country but concentrating efforts and resources is essential in forwarding a unified and NCCP-recognised structure essential in aligning practices according to recognised international standards.”

For more information see:

http://netcancerday.org/irish-and-swedish-net-cancer-experts-join-together-for-inaugural-meeting-of-irish-neuroendocrine-neoplasm-group

http://www.tcd.ie/Communications/news/news.php?headerID=2768&vs_date=2012-11-13


Related posts

Read more about events, news and relevant NETs information

  • Carcinoid Syndrome & Carcinoid Crisis
    The Centre of excellence at St. Vincent’s Hospital have provided us information on prevention and Management of Carcinoid Syndrome & Carcinoid Crisis. Up until now, we … Read more
  • NET Patient Day 2023
    NET Patient Day 2023 has been decided, it will be Saturday 18th of November, beginning at 9 AM. This year we are going back to Cork … Read more
  • The NET Patient Network Is Now A Charity
    For many years patients & family members have asked the NET Patient Network if they can support us. We are a voluntary organisation, so it took … Read more